NCODA 2022 Fall Summit Recap

Two of our BOPA members, Sadia Malik (Digital and E & T Subcommittee member) and Rebecca Devine (Executive committee member) attended the NCODA (National Community Oncology Dispensing Association) Fall Summit kindly funded through BOPA and NCODA’s new collaboration. This international partnership will help both organisations to support one another with sharing guidance, experience and practice to support the horizon scanning of both organisations. Sadia and Rebecca will be presenting their experience and thoughts of the NCODA Fall Summit at the BOPA Symposium 2023.

This newsletter is a summary from NCODA of the presentations and discussions that took place at this summit. We look forward to hearing a more detailed presentation at the BOPA Symposium 2023.

Click here to access the newsletter: https://www.bopa.org.uk/resources/ncoda-2022-fall-summit-recap/

Latest News

By BOPA Research Committee on 25th April 2024

Survey: Pharmacogenomic Panel Testing in Cancer: UK Oncology Professionals

Please consider completing our BOPA member survey on the use of pharmacogenomic panel testing in people with solid tumours. Survey information I’m a pharmacist and pre-doctoral research fellow researching the…

Read article
By BOPA Research committee on 25th April 2024

NIHR Associate Principal Investigator (PI) Scheme is continuing to host Research Learning Lectures

The NIHR Associate Principal Investigator (PI) Scheme is continuing to host the Research Learning Lectures; a series of lectures for anyone in Health and Social Care interested in learning more about research.…

Read article
By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article